|
Aug 6
|
Adma Biologics (ADMA) Q2 Earnings and Revenues Beat Estimates
|
|
Aug 2
|
Puma Biotechnology (NASDAQ:PBYI) shareholders have endured a 70% loss from investing in the stock five years ago
|
|
Jul 28
|
Top Penny Stocks To Watch In July 2025
|
|
Jul 24
|
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2025 Financial Results
|
|
Jul 10
|
Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value Investors
|
|
Jul 2
|
Vertex Gets EU Nod for New Cystic Fibrosis Drug Alyftrek
|
|
Jul 1
|
RCKT's IND for RP-A701 in Dilated Cardiomyopathy Gets FDA Clearance
|
|
Jun 30
|
Vor Bio Stock Skyrockets 250% in the Past Week: Here's Why
|
|
Jun 19
|
Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma
|
|
May 26
|
Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now?
|
|
Feb 23
|
Investors in Puma Biotechnology (NASDAQ:PBYI) have unfortunately lost 73% over the last five years
|
|
Feb 13
|
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results
|
|
Jan 1
|
Is Puma Biotechnology (PBYI) Stock Undervalued Right Now?
|
|
Jul 23
|
Should Value Investors Buy Puma Biotechnology (PBYI) Stock?
|
|
May 28
|
Puma Biotechnology to Join Russell 3000 Index
|
|
May 26
|
With 49% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) has piqued the interest of institutional investors
|
|
May 24
|
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
|
|
May 23
|
Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
|
|
May 5
|
Analysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest Results
|
|
May 4
|
Puma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|